On November 2, 2017, Norris R. Harris, the Company’s controlling shareholder sold and assigned all 100 shares of Series A Preferred Stock (the “Control Stock”) of Start Scientific, Inc. (the “Company”) to OmniElite Holdings LLC (“OmniElite”), and OmniElite’s controlling shareholder Steven Lawrence Brickner for $35,000. The Control Stock is not convertible into common stock but collectively hold 1,000,000,000 voting rights, which amount represents 75.60% of the vote. The Control Stock is entitled to vote together with holders of common stock on all such matters upon which common stockholders may vote. As a result, Mr. Brickner and OmniElite now hold a controlling beneficial interest in the Company and may unilaterally determine the election of the Board and other substantive matters requiring approval of the Company’s stockholders.
News 
Market Data 
Discover 
